pharmaphorum

JULY 27, 2021

Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. per share in the initial deal, which will give it a 64.6% stake in the company.

Drug Delivery 111

Drug Delivery Insulin Cosmetics Development 111

Roots Analysis

MARCH 21, 2022

However, several drug delivery devices that enable patients to self-administer their respective medications are now available. Subcutaneous drug delivery systems – the helping hand for patients. The emergence of safer and patient-friendly devices is acting as a strong enabler for subcutaneous delivery of therapeutics.

Drug Delivery Systems 52

Drug Delivery Systems Drug Delivery Antibody Marketing 52

pharmaphorum

MAY 21, 2021

In SURPASS-4 – the last of Lilly’s registration studies for the dual GLP-1/GIP agonist – tirzepatide met all its primary and secondary objectives, besting treatment with insulin glargine, a long-acting human insulin product that is a mainstay of diabetes treatment, in diabetics with increased cardiovascular risk. Arecor alliance.

Trials 52

Trials Insulin Sales Drug Delivery 52

Roots Analysis

FEBRUARY 22, 2022

Autoinjector As Emerging Drug Delivery Device. The field is presently witnessing several innovations, such as LED / LCD-based visualization, Bluetooth connectivity, dosage recording, safety lock, visual / audible drug delivery confirmation notifications, and automatic drug reconstitution.

Drug Delivery 52

Drug Delivery Production Marketing Development 52

Roots Analysis

SEPTEMBER 18, 2023

Therefore, medical technology is rapidly evolving, enabling more advanced and patient-friendly methods of drug delivery. In the pursuit of creating patient-centric healthcare solutions, the medical industry has witnessed a groundbreaking advancement in drug delivery with the emergence of large volume wearable injectors.

Drug Delivery 52

Drug Delivery Drugs Compliance Marketing 52

BioSpace

NOVEMBER 17, 2022

Editas Medicine is pausing its ocular gene therapy program after demonstrating a favorable safety profile and seeking a potential partner to develop EDIT-101, the company announced Thursday.

Gene Therapy 41

Gene Therapy Gene Gene Editing Medicine 41

Camargo

OCTOBER 14, 2020

Approval of the Month: FDA Approves First Closed-Loop Monitoring and Drug Delivery Device. The FDA has announced its approval of a bluetooth-controlled insulin delivery and monitoring system for use in pediatric patients ages 2 through 6 with Type 1 diabetes.

Development 196

Development Insulin Drug Delivery Production 196

Roots Analysis

SEPTEMBER 22, 2023

These innovative instruments combine precision, convenience, and patient-centered design to revolutionize drug delivery. These devices are equipped with advanced features like programmable dosing, connectivity to mobile apps, and safety mechanisms to ensure accurate and controlled drug delivery.

Drug Delivery 40

Drug Delivery Marketing Insulin Manufacturing 40

pharmaphorum

JUNE 10, 2021

The fundamental misconception among the public, the media and even some lawmakers is that higher drug list prices are the result of drug manufacturers being in a monopolistic position to endlessly raise prices on critical drugs like insulin and then rake in big profits.

Manufacturing 105

Manufacturing Pharma Companies Drugs Pharmacy 105

FDA Law Blog

JANUARY 5, 2023

The current Team Lead for Injection Devices in CDRH’s Division of Drug Delivery and General Hospital Devices and Human Factors noted that depending on the product, the pre-market path for a connected combination product might require an IND, IDE, or a determination that it is a medical device data system , which are not regulated as devices.

Regulation 59

Regulation Production Drug Delivery Insulin 59